This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brandt, C. M. Articles by Steckelberg, J. M. Search for Related Content PubMed PubMed Citation Articles by Brandt, C. M. Articles by Steckelberg, J. M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 08 1995, 1815-1819, Vol 39, No. 8
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase- negative staphylococcal experimental endocarditis

CM Brandt, MS Rouse, BM Tallan, NW Laue, WR Wilson and JM Steckelberg
Infectious Diseases Research Laboratory, Mayo Clinic, Rochester, Minnesota 55905, USA.

The efficacy of cefazolin or cefpirome alone or combined with rifampin was compared with that of vancomycin alone or combined with rifampin in an experimental model of methicillin-resistant, beta-lactamase- producing, coagulase-negative staphylococcal endocarditis. Phenotypically, the mecA gene-positive strain used in vivo did not exhibit methicillin resistance by the agar dilution or disk susceptibility method but was resistant in vitro (oxacillin MIC, 64 micrograms/ml) by the microtiter dilution method with 2% NaCl supplementation. Macrodilution broth susceptibilities of standard inocula failed to demonstrate cross-resistance of staphylococci to cefazolin (MIC, 8 micrograms/ml) or cefpirome (MIC, 4 micrograms/ml). In vivo, vancomycin and cefpirome had similar activities, and both regimens were more effective than was cefazolin alone. While the MIC of rifampin was low (0.031 micrograms/ml), monotherapy with rifampin resulted in a bimodal distribution of outcomes due to the expected emergence of resistant mutants. The results in vitro of time-kill synergy studies using rifampin in combination with cefazolin or cefpirome varied with the antimicrobial concentrations tested and did not reliably predict activities in vivo of rifampin-beta-lactam combination therapies. Cefpirome, but not cefazolin or vancomycin, in combination with rifampin was synergistic in vivo. Cefpirome in combination with rifampin was more effective than was cefazolin in combination with rifampin. Both cephalosporin-rifampin regimens were significantly more effective than was cephalosporin or vancomycin monotherapy and were as effective as vancomycin combined with rifampin. These data support further evaluation of rifampin-beta-lactam combinations as possible alternative therapies to vancomycin-containing regimens for selected methicillin-resistant coagulase-negative staphylococcal infections.

This article has been cited by other articles:

• Pankey, G., Ashcraft, D., Patel, N. (2005). In Vitro Synergy of Daptomycin plus Rifampin against Enterococcus faecium Resistant to both Linezolid and Vancomycin. Antimicrob. Agents Chemother. 49: 5166-5168 [Abstract] [Full Text]  
• Kadurugamuwa, J. L., Sin, L. V., Yu, J., Francis, K. P., Purchio, T. F., Contag, P. R. (2004). Noninvasive Optical Imaging Method To Evaluate Postantibiotic Effects on Biofilm Infection In Vivo. Antimicrob. Agents Chemother. 48: 2283-2287 [Abstract] [Full Text]  
• Arias, C. A., Reyes, J., Zuniga, M., Cortes, L., Cruz, C., Rico, C. L., Panesso, D., on behalf of the Colombian Antimicrobial Resistanc, (2003). Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. J Antimicrob Chemother 51: 59-68 [Abstract] [Full Text]  
• Monzon, M., Oteiza, C., Leiva, J., Amorena, B. (2001). Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 48: 793-801 [Abstract] [Full Text]  
• Amorena, B., Gracia, E., Monzon, M., Leiva, J., Oteiza, C., Perez, M., Alabart, J.-L., Hernandez-Yago, J. (1999). Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 44: 43-55 [Abstract] [Full Text]